T. Rowe Price Associates’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $29.9M | Sell |
|
|||||
|
2019
Q2 | $71.1M | Buy |
|
|||||
|
2019
Q1 | $78.8M | Sell |
|
|||||
|
2018
Q4 | $77.1M | Sell |
|
|||||
|
2018
Q3 | $139M | Sell |
|
|||||
|
2018
Q2 | $251M | Sell |
|
|||||
|
2018
Q1 | $260M | Sell |
|
|||||
|
2017
Q4 | $212M | Buy |
|
|||||
|
2017
Q3 | $341M | Buy |
|
|||||
|
2017
Q2 | $190M | Sell |
|
|||||
|
2017
Q1 | $180M | Buy |
|
|||||
|
2016
Q4 | $152M | Buy |
|
|||||
|
2016
Q3 | $175M | Buy |
|
|||||
|
2016
Q2 | $136M | Buy |
|
|||||
|
2016
Q1 | $74.1M | Buy |
|
|||||
|
2015
Q4 | $93M | Buy |
|
|||||
|
2015
Q3 | $52.5M | Buy |
|
|||||
|
2015
Q2 | $65.9M | Sell |
|
|||||
|
2015
Q1 | $90.4M | Buy |
|